Skip to main content
AS

Aurora Sterilisation

Inactive

Aurora Sterilisation provides a low‑temperature cold plasma system that rapidly inactivates bacteria, viruses, spores and fungi on medical devices without heat, moisture or hazardous chemicals. The technology delivers high‑level disinfection in 5–15 minutes, preserving the integrity of heat‑sensitive and electronic instruments while offering real‑time monitoring and traceability for regulatory compliance.

Rouen, FranceFounded 2019332K+ followers
Updated 2 months ago

Funding

$5.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional sterilization methods such as steam autoclaving, ethylene oxide, and gamma irradiation can be time‑consuming, require high temperatures or toxic chemicals, and may damage heat‑sensitive or delicate medical equipment.

Solution

Aurora Sterilisation offers a cold plasma sterilization system that uses low‑temperature, non‑thermal plasma to inactivate microorganisms on a wide range of medical devices. The technology generates reactive species that achieve high-level disinfection without heat, moisture, or hazardous residues, preserving the integrity and functionality of sensitive instruments. The process is rapid, typically completing cycles in minutes, and can be integrated into existing cleanroom workflows. Results are validated through standard microbiological testing, providing compliance with regulatory sterilization standards.

Target Audience

Primary customers are hospitals, surgical centers, and medical device manufacturers that require rapid, residue‑free sterilization for heat‑sensitive or complex instruments.

Features

  • Low‑temperature (≤45 °C) plasma generated by radiofrequency or microwave excitation
  • Broad-spectrum antimicrobial efficacy against bacteria, viruses, spores, and fungi
  • No chemical residues; by‑products are benign gases that are safely vented
  • Compatible with heat‑sensitive, electronic, and polymer‑based medical devices
  • Short cycle times (5–15 minutes) with automated loading and cycle monitoring
  • Real‑time process monitoring and logging for traceability and compliance
This profile is AI-generated and may contain inaccuracies.